Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/Compare

SYK vs MDT

SYK and MDT side by side — valuation & fundamentals (public data).

Key statistics

SYK vs MDT key statistics
MetricSYKSTRYKER CORPMDTMedtronic plc
Market cap$108.02B$119.94B
P/E (TTM)29.223.1
P/B9.212.39
P/S4.3x3.3x
Dividend yield1.19%3.03%
Revenue$25.84B(TTM)$37.54B(TTM)
Revenue growth (YoY)11.2%8.4%
Net income$3.73B(TTM)$430.00M(TTM)
Earnings growth (YoY)8.5%3.0%
EPS, diluted$9.65(TTM)$4.06(TTM)
EBIT margin19.5%17.8%
ROE27.7%0.0%
ROIC15.1%7.0%
Piotroski F8/98/9
1y total return-24.5%+3.4%

Figures from SEC filings · for reference only · not investment advice

Growth of $10,000: SYK vs MDT

$10.0K$28.1K$14.7K2016-05-122026-09-15
MetricSYKMDT
End value$28.1K$14.7K
Total return+181.4%+47.5%
CAGR+10.5%+3.8%
Volatility26.7%23.3%
Sharpe0.360.10
Sortino0.510.14
Max drawdown-43.8%-45.3%

Based on 2600 common trading days, 2016-05-12 → 2026-09-15 · risk-free 4.11% (current short-Treasury, held constant)

A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.

Related comparisons

ISRG vs SYKISRG vs MDTMDT vs SYKBSX vs MDTBSX vs SYKSYK vs ZBH

Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)